Stockman Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Sell
5,056
-1,168
-19% -$272K 0.14% 73
2025
Q4
$1.29M Sell
6,224
-191
-3% -$37.8K 0.15% 71
2025
Q3
$1.19M Sell
6,415
-226
-3% -$38.7K 0.15% 71
2025
Q2
$1.01M Sell
6,641
-373
-5% -$57.3K 0.14% 75
2025
Q1
$1.16M Sell
7,014
-139
-2% -$21.7K 0.17% 67
2024
Q4
$1.03M Sell
7,153
-316
-4% -$49K 0.16% 68
2024
Q3
$1.21M Buy
7,469
+26
+0.3% +$4.14K 0.19% 64
2024
Q2
$1.09M Sell
7,443
-442
-6% -$65.7K 0.19% 66
2024
Q1
$1.25M Sell
7,885
-626
-7% -$99.6K 0.22% 63
2023
Q4
$1.33M Sell
8,511
-2
-0% -$307 0.27% 59
2023
Q3
$1.33M Sell
8,513
-974
-10% -$161K 0.29% 60
2023
Q2
$1.57M Sell
9,487
-1,070
-10% -$173K 0.34% 55
2023
Q1
$1.64M Sell
10,557
-458
-4% -$74K 0.37% 55
2022
Q4
$1.95M Buy
11,015
+325
+3% +$56.1K 0.45% 50
2022
Q3
$1.75M Buy
10,690
+46
+0.4% +$7.78K 0.47% 48
2022
Q2
$1.89M Buy
10,644
+275
+3% +$49K 0.48% 47
2022
Q1
$1.84M Sell
10,369
-1,468
-12% -$250K 0.38% 50
2021
Q4
$2.02M Sell
11,837
-60
-0.5% -$9.82K 0.41% 52
2021
Q3
$1.92M Buy
11,897
+31
+0.3% +$5.29K 0.43% 52
2021
Q2
$1.96M Buy
11,866
+21
+0.2% +$3.48K 0.47% 50
2021
Q1
$1.95M Sell
11,845
-185
-2% -$29.9K 0.54% 48
2020
Q4
$1.89M Sell
12,030
-23
-0.2% -$3.39K 0.58% 51
2020
Q3
$1.79M Sell
12,053
-90
-0.7% -$13.3K 0.65% 48
2020
Q2
$1.71M Buy
12,143
+593
+5% +$86.4K 0.64% 47
2020
Q1
$1.51M Sell
11,550
-829
-7% -$118K 0.67% 46
2019
Q4
$1.81M Sell
12,379
-75
-0.6% -$10.2K 0.64% 46
2019
Q3
$1.61M Buy
12,454
+225
+2% +$29.6K 0.62% 47
2019
Q2
$1.7M Sell
12,229
-95
-0.8% -$13.2K 0.7% 48
2019
Q1
$1.72M Sell
12,324
-1,195
-9% -$160K 0.75% 44
2018
Q4
$1.75M Sell
13,519
-425
-3% -$59.3K 0.83% 41
2018
Q3
$1.93M Sell
13,944
-505
-3% -$67.1K 0.83% 42
2018
Q2
$1.75M Buy
14,449
+750
+5% +$93.6K 0.8% 44
2018
Q1
$1.76M Sell
13,699
-31,273
-70% -$4.23M 0.8% 44
2017
Q4
$6.28M Sell
44,972
-514
-1% -$71.6K 2.82% 2
2017
Q3
$5.91M Buy
45,486
+23,843
+110% +$3.16M 2.83% 2
2017
Q2
$2.86M Sell
21,643
-21,851
-50% -$2.79M 2.86% 3
2017
Q1
$5.42M Buy
43,494
+1,387
+3% +$166K 3.08% 1
2016
Q4
$4.85M Buy
42,107
+1,883
+5% +$218K 2.95% 1
2016
Q3
$4.75M Sell
40,224
-1,601
-4% -$194K 2.94% 2
2016
Q2
$5.07M Sell
41,825
-1,249
-3% -$142K 3.97% 1
2016
Q1
$4.66M Sell
43,074
-316
-0.7% -$32.7K 3.7% 2
2015
Q4
$4.46M Sell
43,390
-239
-0.5% -$24K 3.61% 2
2015
Q3
$4.07M Buy
43,629
+3,839
+10% +$371K 3.51% 2
2015
Q2
$3.88M Buy
39,790
+1,296
+3% +$130K 3.3% 4
2015
Q1
$3.87M Buy
38,494
+371
+1% +$37.7K 3.31% 4
2014
Q4
$3.99M Buy
+38,123
New +$4.02M 3.41% 4

Other funds holding JNJ

Stockman Wealth Management's JNJ Position: Q1 2026 in Review

Stockman Wealth Management reduced its Johnson & Johnson (JNJ) stake by 19% in Q1 2026, selling an estimated $272K and leaving 5,056 shares worth $1.24M. The position accounts for 0.14% of the portfolio, ranked #73.

Stockman Wealth Management first reported a position in JNJ in Q4 2014 and has held it in 46 quarters since. The position peaked at $6.28M in Q4 2017. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Stockman Wealth Management held 5,056 shares of Johnson & Johnson worth $1.24M as of Q1 2026.
  • Stockman Wealth Management sold 1,168 Johnson & Johnson shares in Q1 2026, an estimated $272K.
  • Johnson & Johnson made up 0.14% of Stockman Wealth Management's portfolio in Q1 2026, its #73 holding.
  • Stockman Wealth Management first reported a position in Johnson & Johnson in Q4 2014 and has held it in 46 quarters since.
  • Stockman Wealth Management's Johnson & Johnson position peaked at $6.28M in Q4 2017.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Stockman Wealth Management's 13F filing for Q1 2026, filed 13 Apr 2026.